Treading the thin line: pharmacy workers’ perspectives on medication abortion provision in Lusaka, Zambia by Footman, Katharine et al.
Treading the Thin Line: Pharmacy
Workers’ Perspectives on Medication
Abortion Provision in Lusaka, Zambia
Katharine Footman, Nachela Chelwa, Megan Douthwaite,
James Mdala, Drosin Mulenga, Caila Brander, and Kathryn Church
Context: Despite liberal abortion laws, safe abortion access in Zambia is im-
peded by limited legal awareness, lack of services, and restrictive clinical poli-
cies. As in many countries with restricted abortion access, women frequently
seek abortions informally from pharmacies. Methods: We conducted 
in-depth interviews in  to understand the experiences and motivations
of pharmacy workers who sell medication abortion (MA) drugs in Lusaka.
Results: We found that pharmacy staff reluctantly assume a gatekeeper role for
MA due to competing pressures from clients and from regulatory constraints.
Pharmacy staff often decide to provideMA,motivated by their duty of care and
desire to help clients, as well as financial interests. However, pharmacy work-
ers’ motivation to protect themselves from legal and business risk perpetuates
inequalities in abortion access, as pharmacy workers improvise additional eli-
gibility criteria based on personal risk and values such as age, partner approval,
reason for abortion, and level of desperation. Conclusion: These findings
highlight how pharmacy staff informally determine women’s abortion access
when laws and policies prevent comprehensive access to safe abortion. Reform
of clinical guidelines, public education, strengthened public sector availability,
task sharing, and improved access to prescription services are needed to ensure
women can legally access safe abortion.
INTRODUCTION
Although abortion is a simple and safe medical process that can be delivered by low-level
health workers with adequate training (WHO 2012, 2015), almost half of the 73 million abor-
tions that occur each year are unsafe, due to laws, policies, social stigma, and health sys-
tem weaknesses that limit women’s access to safe abortion care (Ganatra 2017, Bearak 2020).
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 Pharmacy Workers’ Perspectives on Medication Abortion in Zambia
Abortion is more legally restricted in low- and middle-income countries, and 97 percent of
unsafe abortions occur in these contexts (Singh 2018). Even in countries where the law allows
women to have an abortion for a wide range of indications, safe abortion care can be made
inaccessible by policies that restrict who can provide abortion, and where and how it can be
provided (Singh 2018).
In recent years,medication (ormedical) abortion (MA) sold by pharmacies (with orwith-
out accompanying information and advice for administration) has reduced the incidence
and severity of complications from unsafe abortion in low- and middle-income countries
(Harper 2007, Sherris 2005, Miller 2005). Pharmacy provision of MA has improved access
to safer abortion care where abortion is legally restricted, such as countries in Latin America
(Lara 2006), andwhere other regulatory barriers preventwomen fromaccessing care formally
through the health system, for example, India (Singh 2018). Pharmacies are able to sell the
medication misoprostol for abortion, even in legally restricted settings, as the drugs are reg-
istered for other indications such as gastric ulcer. Pharmacies can also sell the more effective
combined regimen of mifepristone and misoprostol, but this combination product is only
indicated for medical abortion, so it tends to be less readily available (Footman 2018). MA
can be safely provided by pharmacy workers with adequate training (Tamang 2018). Studies
in Asia and sub-Saharan Africa have found MA that is self-managed (administered with-
out clinical supervision) after purchasing medications from pharmacies can result in clini-
cal outcomes comparable to MA provided formally through clinics (Tamang 2018; Stillman
2020). However, studies in low- and middle-income countries have documented challenges
in the quality of pharmacy provision, as pharmacy workers often do not provide adequate
information about how to safely and effectively use the medications (Footman 2018). Addi-
tionally, products (WHO 2016) and product information inserts (Frye 2020) can be of poor
quality. Despite these challenges, pharmacy provision of MA is considered a harm reduction
approach that can reduce mortality and morbidity from unsafe abortion (Hyman 2013).
Beyond the public health benefits of pharmacy access to MA, these pills are often seen
as an agent of social change that can shift power dynamics and reduce health inequali-
ties by enabling women to take more control over their own health and bodies, and by
reconceptualizing the woman herself as the provider of care (Berer 2018; Erdman 2018;
Oppegaard 2018). However, studies in countries where abortion is legally restricted (Tan-
zania, Burkina Faso) have also identified that pharmacy provision of MA can be reliant
on the will of the vendor (Solheim 2020) and on having adequate social networks and
power to negotiate access to the drugs (Drabo 2019). A study in Uttar Pradesh, India, also
identified that gendered inequalities in access to information can be reinforced by male-
dominated pharmacy environments (Diamond-Smith 2019).
Study Aims
This qualitative study aimed to understand the experiences of pharmacy workers who sell
MA in Lusaka, Zambia, to inform efforts to improve the quality of their provision practices.
The in-depth interviews were intended to explore the perspectives of pharmacy workers on
the practice of women’s self-management of MA from pharmacies, and their values, motiva-
tions, and beliefs surroundingMA provision. Although studies have explored the knowledge
and practices of pharmacy staff in Zambia (Hendrickson 2015; Fetters 2014) and elsewhere
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(Footman 2018), research to better understand pharmacy workers’ motivations and perspec-
tives is needed to further improveMA provision. AlthoughMA provision by pharmacies has
improved access to safe abortion methods, lack of accurate information and poor-quality
products can negatively affect women’s experiences of self-managing MA from pharmacies.
Abortion in Zambia
Zambia has one of the least restrictive abortion laws in sub-Saharan Africa. The 1972 Termi-
nation of PregnancyAct permits abortion on awide range of grounds, including if continuing
a pregnancy involves a risk to the life of the pregnant woman, her physical or mental health
or that of any of her existing children, or if a child born of the pregnancy would suffer from
physical or mental abnormalities (Government of Zambia 1972). The Penal Code was up-
dated in 2005 to include rape or defilement of a female child as an indication for abortion.
The law also allows providers to consider the woman’s (actual or foreseeable) circumstances
and her age, when assessing the legal indications for an abortion (Government of Zambia
1972). Ministry of Health guidelines permit MA up to nine gestational weeks and manual
vacuum aspiration up to 12 weeks (or 14 weeks under certain circumstances) (Government
of Zambia 2017). However, Zambian women have limited access to safe, quality abortion care
due to poor service availability (Ministry of Health 2009; Cresswell et al. 2018), restrictive
clinical regulations on who can provide care coupled with health worker shortages, health
care provider refusal to offer abortion care (Freeman 2019), and poor awareness of abortion
laws (Ministry of Health 2009; Coast 2016). One of the legal requirements for a woman to
access an abortion is signatures of approval from three medical doctors, including a special-
ist, except in emergency cases (Government of Zambia 1972), which creates challenges in the
context of severe health worker shortages (Prust 2019).
The 1972Act allowed theMinister ofHealth tomake regulations for better carrying out of
the provisions of the Act by statutory instrument, and there has recently been more progress
in the regulations surrounding abortion. New comprehensive abortion care guidelines pub-
lished in 2017 enabled clinical officers, medical licentiates, and other health practitioners
listed in the 2009 Health Professions Act to provide safe abortion services, as well as medical
doctors (Government of Zambia 2017). The guidelines also clearly defined emergency cir-
cumstances to include the risk of unsafe abortion, allowing a single medical doctor to certify
the procedure if a woman were considered at risk (Government of Zambia 2017). However,
safe abortion laws and guidelines are still poorly disseminated and not well known among
women and providers (Blystad 2019). Political leaders and policy makers have often been
unwilling to take visible measures that improve access to abortion, in part because the decla-
ration of Zambia as a Christian Nation has had a significant impact on politics and on health
workers’ willingness to be involved in legal abortion services (Haaland 2019). Additionally,
providers are fearful of offering abortion services because those seeking or providing abor-
tion under circumstances in which it is not permitted under the current law can face harsh
punitive measures (7–14 years imprisonment) (Government of Zambia 2012).
In theory, safe abortion services are available at public health facilities (for free, though
unofficial provider payments are common (Leone 2016)), as well as nongovernmental or-
ganization and private facilities. However, in practice, the availability of safe abortion care
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in public facilities is limited. A recent study of Central Province found that only 21 percent
of women lived within 15 km of a facility with basic capacity to provide safe abortion care
under Zambia’s law for non-emergency scenarios (Cresswell et al. 2018). These factors have
combined to create high levels of unsafe abortion: 70 percent of all pregnancy terminations
in the country were estimated to be unsafe in 2009 (Ministry of Health 2009), almost four
decades after the abortion law was originally reformed. More recent data on abortion inci-
dence and safety is lacking, but the 2017 comprehensive abortion care guidelines stated that
abortion is one of the top five causes of maternal mortality, and that 30–50 percent of acute
gynecological admissions are due to unsafe abortion complications (Government of Zambia
2017).
The combination pack of mifepristone and misoprostol for MA has been registered for
use in Zambia since 2012 and can be legally purchased from a pharmacy with a valid prescrip-
tion that has the required doctor approvals for the abortion (Ministry of Health 2009). The
1972 Termination of Pregnancy Act stated that abortions must be performed in a hospital
or place designated by the Ministry of Health, and in 2017 the Ministry of Health guide-
lines stated that MA can be taken at a facility or at home. The 2017 guidelines also state that
mifepristone–misoprostol or misoprostol-only regimens can be used for MA, and that pa-
tientsmust be informed about efficacy, side-effects, and risks and given an emergency contact
if self-administering at home. Before the approval of the combination-pack, pharmacies were
known to be providing the less clinically effective regimen ofmisoprostol alone informally for
abortion (Hendrickson 2016), and provision of ineffective medications for abortion such as
emergency contraceptive pills and contraceptives, or uterotonics such as pitocin or oxytocin
have also been documented (Fetters 2014).
METHODS
We conducted in-depth interviews with 16 pharmacy workers between September and De-
cember 2019.
The in-depth interviews presented in this paper were part of a larger study that evalu-
ated an intervention which aimed to increase women’s access to accurate information about
MA through a hotline (under analysis). The intervention involved the promotion of a repro-
ductive health advice hotline to clients purchasing MA through pharmacies. Promotional
materials included posters, banners, pocket cards, branded lab coats / t-shirts for pharmacy
staff, and stickers on MA products. These in-depth interviews were also intended to explore
participants’ perceptions of the intervention and were conducted 10–12 months after the in-
tervention had been implemented.
Sample
We approached individuals working at the pharmacies that were included in the inter-
vention evaluation in Lusaka. The pharmacy intervention inclusion criteria were that the
pharmacy was known to sell the MA combination pack, had a valid operating license,
the pharmacy manager and at least one worker were willing to participate and were able
to give informed consent, workers were age 18 or over, and the pharmacy had a private
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dispensing room. Among 39 pharmacies approached, 22 agreed to participate in the inter-
vention (56 percent). From these pharmacies, we selected pharmacy workers for interview
based on the recommendation of pharmacy owners. The only additional inclusion criteria
for the in-depth interview was that the pharmacy worker was known to be responsible for
selling MA. Sixteen pharmacy workers agreed to take part (eight men, eight women) out of
22 pharmacies approached. Only one pharmacy worker was interviewed per pharmacy. Par-
ticipants gavewritten, informed consent to take part in the research andwere given the option
to withdraw at any time. Participants were not compensated for taking part in the in-depth
interview.
Data Collection
Interviews were conducted by two researchers from Population Council (DM, CB) and two
trained qualitative interviewers. All interviewers were female, experienced in conducting
qualitative interviews, and received training in the research subject area. Debrief meetings
between interviewers and researchers were conducted immediately after each interview to
discuss key points from the interview, how questions were being received, and any changes
required to the topic guide and interview process. Interviews took place in a private space in
the pharmacy and were between 45–60 minutes long. We used a semistructured topic guide.
The topic guide included background information about the participant and the pharmacy
they worked at; their reasons for, concerns about and experiences of selling MA; the pric-
ing of MA; perceptions of the intervention and of the reproductive health hotline; and their
opinions about howMA clients could be better supported. The topic guide was reviewed and
updated during data collection after the first two transcripts were reviewed by the study team.
All interviews were conducted in English (preferred by the participant), recorded, and tran-
scribed verbatim. Transcription was completed by the interviewers with support from a third
research assistant.
Analysis
Transcripts were imported into Dedoose for analysis. Initial coding began during data collec-
tion, but the analysis was completed after all interviewers were conducted. We used thematic
analysis (Attride-Stirling 2001): following an initial review of five transcripts, we developed
a set of descriptive codes and two of the researchers (MD, KF) independently coded the five
transcripts. The remaining transcripts were then coded by one researcher (MD). The codes
were summarized into memos, and broad themes were identified. Coded excerpts were then
reread and resummarized in order to further develop these themes.
Ethics
The research received ethical approvals from the ERESConverge ethics committee in Zambia
(2017-Sep-028), the MSI Reproductive Choices Independent Ethics Committee in the UK
(010-19A), and the Population Council Institutional Review Board in the United States (861).
The data that support the findings of this study are available from the corresponding author
upon reasonable request.
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RESULTS
Participant Characteristics
Participants had a mixture of backgrounds and levels of experience: some were pharmacy
employees who had only worked a few years, others had 10–20 years’ experience in the pub-
lic, NGO, or private sector. Most (12) were pharmacists or pharmacy technologists with a
degree or diploma in pharmacy, but the remainder worked in sales, logistics, or management
of the facilities. Of the pharmacies, most were retail, but three were wholesale pharmacies,
and the sample included both chain pharmacies and lone outlets. The sites varied in terms
of number of clients seen per day (50–400) and the number of staff employed (3–20) and
provided a range of services including over the counter and prescription medicines, tests for
blood pressure, cholesterol, diabetes, HIV and malaria, and cosmetic sales. Participants had
worked on average for five years at their current pharmacies, and half were owners or man-
agers of the pharmacy. Of the 13 retail pharmacy employees, all had day-to-day experience of
serving clients and dispensingmedicines as well as ordering andmanaging stock, monitoring
drug storage and expiry, accounting, and supervision of staff.
Qualitative Findings
The main themes that arose from the findings were: the competing pressures experienced
by pharmacy workers over the provision of abortion medications; the gatekeeping role that
pharmacy workers reluctantly assumed as a result of these pressures; and the conflicting mo-
tivations (moral, risk-related and financial) that pharmacy workers navigate when making
decisions about providing MA.
On the Frontline: Facing Conflicting Pressures
Pharmacyworkers operate at the frontline of the health system, and as a result they experience
conflicting pressures: from clients who need a safe abortion but cannot access care formally
through the health system; from regulation which limits pharmacists’ role as providers of safe
abortion; and from their own conflicted internal values around abortion.
Pharmacy workers reported commonly receiving requests for MA from a diverse range
of clients in terms of age, relationship status, and gender. They receive clients purchasing
the medications for themselves or for others, sometimes with a prescription but more
commonly without one. Pharmacy workers often displayed compassion and empathy when
talking about the predicaments faced by these clients, and a desire to help them through an
often-desperate situation. Pharmacy workers described feeling pressure to provide abortion
medications, even to clients who did not have a prescription, as they were aware that women
struggled to access safe abortion through the formal health system:
There are clients that would come, they don’t want to go to the hospital, she
knows she is pregnant and maybe she has a baby – she cannot keep that -
then she has come to you to say, ‘my brother I need your help, it’s this and this
and this’… yeah you would help in such cases. [Male pharmacy technologist;
diploma; 1 year experience]
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Pharmacy workers were aware of the challenges their clients faced when trying to access
prescriptions: “it’s usually because it’s not easy to get a prescription from the hospital for such
drugs so they prefer that they just talk to a pharmacy personnel” [male pharmacy technolo-
gist; diploma; 2 years’ experience]. Although abortion can be provided at lower level health fa-
cilities in Zambia, the hospital was the only alternativementioned by pharmacy staff, possibly
due to the requirement for doctors’ signed approvals. Hospitals and doctors were perceived
to be likely to refuse to provide abortion care: “you know i can tell you 80% of doctors, if the
patient goes with a genuine problem, still they don’t understand and they refuse the abor-
tion” [male pharmacist; bachelor degree; 20 years’ experience]. Clients were also perceived
to want to avoid hospitals due to confidentiality and quality concerns. One pharmacy worker
described how clients “don’t want to go to the hospital… they say the nurses are mean” [male
pharmacist; bachelor degree; 4 years’ experience], while another explained that “if they go to
the government hospital to get a physical, that way they’ll have a curettage” [male pharmacist
and pharmacy owner, bachelor degree, >20 years’ experience].
Most of the participants were aware that they should only sell abortion medications with
a prescription, but a few were uncertain about the legal status of abortion. The uncertainty
about abortion laws was also perceived to be felt by doctors, who turned clients away: “ahh
it’s a risk so sometimes doctors refuse to do the abortion, that’s why they come here with the
stress” [male pharmacist; bachelor degree; 20 years’ experience]. There was also uncertainty
in the wider community. This created additional pressure for pharmacy staff who had to ex-
plain prescription requirements to clients and sometimes faced anger if they refused to sell
without a prescription. Pharmacy staff therefore had to balance the legal requirement for a
prescription with the pressure from clients who needed access to MA, and made pragmatic
decisions based on their personal preferences and comfort, with one participant describing
themselves as “more of a prescription type of person.”
Most pharmacy staff responded to these competing pressures by providing the drugs
without a prescription in some cases. However, provision of MA could also clash with their
internal values and beliefs. Most participants expressed pragmatic views on abortion, seeing
it as a much-needed health service that is “safer for our communities” and acknowledging
that “you can’t stop them” if a woman has decided to end a pregnancy. However, a few phar-
macy workers described abortion as a “sin.” While one participant expressed that abortion
“is not something that needs to be hidden, it is not something that womenfolk need to feel
bad and guilty about,” he also acknowledged how provision of the medication could clash
with the beliefs and values of pharmacy staff:
Health practitioners and pharmacists more so, we are also religious people and
youwill find in a lot of instances, what you do as a pharmacist or a health profes-
sional - clashes with your beliefs and principles and norms. So you need to tread
carefully, and there’s a thin line—in terms of what to do and how to do it. I have
colleagueswho have completely distanced themselves from the vice because it is
believed that it is against biblical principles. [Male pharmacist; bachelor degree;
9 years’ experience]
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Pharmacy Workers as Reluctant Gatekeepers
Pharmacy workers described reluctantly taking on the position of a gatekeeper for abortion
care, as they are forced to make decisions about who can access care whilst balancing their
clients’ needs with policy and health system constraints, and their own internal values:
There is that religious point of view formost of us, I think, so there is a very thin
line between being a professional and trying to be religious… so bear with us
if we don’t assist all customers [laughs]. [Female pharmacist; bachelor degree;
5 years’ previous experience]
In response, pharmacy staff develop their own sets of rules and eligibility criteria, with
clients being requested to provide certain information to pharmacy workers to inform their
final decision:
There are very few cases where I help out… when the customer really just ex-
plains to me why they need it… I do ask a lot of questions why they really need
it before I even give them… if I am not convinced, I will not assist. [Female
pharmacist; bachelor degree; 6 years’ experience]
While some eligibility criteria imposed by pharmacy staff were legal or clinical cri-
teria such as gestational age or possession of a prescription, other social requirements
were improvised by pharmacy staff. These social criteria included the woman’s reason for
having an abortion, whether their partner or parent was aware and supportive, whether
their age indicated they were mature enough to manage the process, whether they seemed
desperate, whether they seem emotionally ready and whether they had tried to end the
pregnancy already. If pharmacy workers did not feel that clients met these criteria, the
clients could be denied care (as above) or charged a higher price to make the medications
unaffordable:
The students and those will misuse, will abuse the drug. If they come, I will wait
to sell them but if they bother too much then I give them the higher price so
that they don’t buy. [Male pharmacist; bachelor degree; 20 years’ experience]
Alternatively clients may have to spend longer negotiating access, for example, this par-
ticipant explained how she first advises the client against the abortion, but will eventually
provide the medications if she hears compelling reasons for ending the pregnancy:
Interviewer: You mentioned “we are not for the idea at first” so are there times
where you discourage them to say: “no you shouldn’t do this”?
Participant: Yeah there are times; because you have to do that so that you know
how serious they want this so that they kindly revisit their decision. [Female
pharmacy technologist; diploma; >5 years’ experience]
Pharmacy workers needed to trust the clients in order to provide the medications. They
commonly feared clients would lie about gestational age to gain access: “a lot of people like
to lie about it and say ‘no it is just some days old or weeks old’, meanwhile it is a very
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big pregnancy” [female pharmacist; bachelor degree; 6 years’ experience]. In order to feel
comfortable dispensingMA, the pharmacy staff also described needing to trust in the client’s
ability to manage the process, avoid complications, and avoid unsafe methods.
Motivations of Pharmacy Workers
Pharmacy workers’ gatekeeping decisions seemed to be underpinned by multiple motiva-
tions: risk management, moral, and financial concerns.
Risk management was an important concern for many of the pharmacy workers. Par-
ticipants feared their clients would experience complications due to taking the medications
incorrectly, which created a great deal of anxiety for pharmacy workers: “usually when I even
dispense those medicines I always sit and pray: let it just go well, let it just go well, that’s how
it is” [male pharmacy technologist; diploma; 1 year experience]. Concerns about risk were
related to clients’ wellbeing but were sourced in the fear that a complication would create
problems for the pharmacy: “when clients are asking for this medication believe me they are
nice, they are very nice people, but if anything happens to their bodies they will backfire and
pin it on you” [female pharmacist; bachelor degree; 6 years’ experience]. Participants were
also concerned that the clients’ previous use of unsafe methods would cause complications
and clients would “come and point at us”. For most pharmacy staff, their stated preference
would be to sell MA with a prescription to reduce their liability and ensure the process is
well-supported (given their own lack of training) in case of adverse outcomes:
It’s good in away that, when a client comeswith a prescription, it assuresme that
it’s under supervision by registeredmedical personnel yes…where a person just
comes you know empty-handed…you know the person could be in danger and
stuff, and that could put me in it. [Female pharmacist; bachelor degree; 4 years’
experience]
We did not directly ask participants, but pharmacy workers were not specific about what
“trouble” would be caused if they were found to be providing MA without a prescription. A
couple of the participants mentioned the risk of inspectors, but participants did not mention
specific risks such as business closure, legal action, or arrest. Risks were managed by ensur-
ing clients had a prescription (some even turned down sales), providing antibiotics, and using
personal phones to stay in touchwith clients “until everything is done.” The eligibility criteria
improvised by pharmacy workers also helped them to manage risk. For example, pharmacy
workers described ensuring the partner was involved because a partner finding out about an
abortion later could “trickle back down to us here” or denying care to younger girls who they
did not think could cope with the process because “we feel they are too young and maybe
when we give them, something bad happens to them, they can still come back. They are not
mature enough to handle the situation” [female pharmacy owner; secondary school educa-
tion; 10 years’ experience].
Moral language was also used to describe gatekeeping decisions, as pharmacy workers
assessed whether clients were the “right person, the one who really needs it” [male pharma-
cist; bachelor degree; 7 years’ experience]. Several pharmacy staff framed dispensing of MA
as part of their duty of care and role as health professionals, and as an important way of pre-
venting harm from unsafe abortion. The same participant who discussed how provision of
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the medication could clash with the beliefs and values of pharmacy staff also explained: “it is
something that is difficult for us to do in certain instances. But we swore an oath that we will
protect the public and serve the masses. So that’s that” [male pharmacist; bachelor degree;
9 years’ experience]. Both public health and rights language were used to justify gatekeeping
decisions: their actions were described as “helping” and “necessary,” making communities
safer by preventing unsafe abortion as well as upholding “freedomof choice.” Some expressed
awareness of the complex paths women may be forced to take if they denied them care: “we
don’t bounce the people you know, they can get the medicines easily you know, instead of go-
ing round and then you know they get stressed” [male pharmacist; bachelor degree; 20 years’
experience], and compassion for the challenging circumstances their clients faced: “most of
them are coming from places where the men in their lives are not even supportive, so there
is all those issues” [female pharmacist; bachelor degree; 6 years’ experience].
Financial motivations were also evident in some of the pharmacy workers’ descriptions
of their gatekeeping decisions, as some made clear that “of course on the personal interest,
again, there is money” and considered the product a profitable medication. However, most
only mentioned the need to prevent unsafe abortion when asked about the benefits of sell-
ing MA. In addition, financial decisions about, for example, coselling antibiotics or “blood
boosters” (iron capsules or syrup, folic acid) with MA were also portrayed as moral ones:
“no, its business but again at the end of the day, you are still doing the right thing” as these
products were (incorrectly) perceived to reduce risk of complications. Pricing strategy was
also used moralistically by one pharmacy worker, with high prices used to prevent provision
to some individuals who would “misuse” or “abuse” the drug, as compared to “genuine” peo-
ple. Prices reported by pharmacy workers varied from 120–500 Kwacha (USD $6.60–27.50).
Most pharmacy workers would not reduce prices for those who could not afford the med-
ications, with some making clear that “this is not a charitable organization” and “we are
here to make money.” However, there were some who described charging prices based on
what they thought the client could afford, or agreeing lower prices to help individuals access
the drugs.
DISCUSSION
This study found that pharmacy workers selling MA in Lusaka felt caught between regula-
tions that limit women’s access to safe abortion, their own conflicted personal values, and
their desire to prevent unsafe abortions. Pharmacy workers reluctantly assume the role of
gatekeeper for safe abortion methods, and often decide to provide MA, motivated by their
duty of care as well as financial interests. However, pharmacy workers’ motivation to pro-
tect themselves from legal and business risk perpetuates inequalities in access to safe abor-
tion care, as pharmacy workers improvise additional eligibility criteria based on personal
risk and values such as the client’s age, partner approval, reason for abortion, and level of
desperation. These findings highlight the impact that limited implementation of abortion
law reform and health system failures surrounding abortion have had on pharmacy staff.
In recent years, progress has been made in expanding availability of MA and decentraliz-
ing care in Zambia (Fetters 2017), but the law remains ambiguous and this ambiguity can
be used by those who seek to limit access to safe, legal abortion, as well as those who wish
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to increase access (Haaland 2019). Stigma surrounding abortion prevents abortion-related
issues being addressed in policy meetings and public settings (Haaland 2020), and while
abortion policy issues are silenced or ignored, frontline workers such as pharmacy staff are
forced into the conflicted position of making pragmatic decisions about who can access
abortion care.
Pharmacies are often viewed primarily as businesses (Lowe 2009) but beyond the
financial incentive for selling MA, gatekeeping decisions are motivated by personal and
professional liability as well as moral values. Caught between urgent demands from clients
and an uncertain regulatory environment, pharmacy staff act as street-level bureaucrats
(Lipsky 1980). Pharmacists effectively translate policies intro practice as they are forced to
make decisions about who can access safe abortion care. Decisions are based on a desire to
avoid harm from unsafe abortion while protecting their moral values, financial motivations,
and perceived personal risk and liability. Lipsky’s theory of street-level bureaucracy has
previously been applied to abortion care in Ghana (Aniteye 2013) in research that identified
how abortion policy implementation can be limited by midwives and doctors’ values and
attitudes, and their balancing of personal and professional dilemmas. By contrast, in this
study, personal and professional dilemmas caused pharmacy staff to extend their practice
beyond Zambia’s policy framework, making pragmatic decisions about how to prevent
unsafe abortion in response to the health system’s failure to make safe abortion accessible for
women. Though pharmacy staff sometimes made decisions that limited safe abortion access
to protect themselves and their businesses, they spoke with empathy and compassion about
the challenges faced by clients who need a safe abortion and saw the provision of MA as part
of their professional ethics and duty of care.
Pharmacy workers’ willingness to provide MA is known to reduce harm from unsafe
abortion (Miller 2005; Sherris 2005; Harper 2007), but the potential impacts of pharmacy
provision on reproductive rights and on health inequalities may be limited by their conflicted
morals and motivations. For example, the criteria used by pharmacy staff to decide who can
access care may contribute to inequalities in the safety of abortion, as those most likely to be
turned away are younger, without partner or parental support, unable to afford to pay higher
prices, and less trusted to be able to manage the abortion process in the eyes of the phar-
macy worker. The impact of gender on access to safe abortion in Zambia has previously been
identified (Freeman 2017). The finding that pharmacists may turn away clients who do not
have male support provides evidence of one of the mechanisms through which these gender
inequities may be reinforced. Pharmacies can play an important role in reducing unsafe abor-
tion as they are on the frontline of the health system.However, being positioned outside of the
abortion law in Zambia, without formal supporting structures to ensure they offer safe abor-
tion care, means they can perpetuate health inequalities that impact most on younger, poorer
women.
The research highlights the need for laws, policies, and regulations to ensure that women
can access high quality abortion care, without facing fear of provider refusal. It has been
estimated that the Zambian health system could save as much as US$0.4 million annually
if women being treated for unsafe abortion had a safe abortion instead (Parmar 2017). In
Zambia, increasing access could mean removing the requirement for doctors’ signatures
and enabling task-sharing of abortion to mid-level providers, a proven safe and effective
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practice (Barnard et al. 2015; WHO 2015). Public awareness of abortion laws and rights must
be increased through awareness campaigns, and clear communication to health care profes-
sionals and regulatory bodies is needed to raise their knowledge of abortion laws. Use of phar-
macists, as well as midlevel providers, has previously been recognized as an opportunity for
increasing access to safe abortion care and reducing costs of unsafe abortion in Zambia
(Leone 2016). Pharmacies can offer an important source of MA and are known to be able
to provide care safely with adequate training and support (Tamang 2018). Interventions that
enable pharmacies to workmore closely with providers offering prescription and counselling
services, for example, through telemedicine approaches or hotlines, could improve legal ac-
cess to safe abortion care in Zambia (Endler 2019; Gerdts 2020). The Covid-19 pandemicmay
offer an important impetus to rapidly deliver such regulatory or systemic change, since stud-
ies are beginning to show that women’s access to abortion in health facilities is even more
restricted than before (Riley 2020). Finally, pharmacy staff expressed conflicting values sur-
rounding abortion, which in part determined the criteria used to decide who can access care.
Values clarification and attitude transformation materials or workshops for pharmacy staff
may support more equitable access to safe abortion (Turner 2018), though the sustainability
of such interventions may be limited in the pharmacy context.
LIMITATIONS
This research has several limitations. The topic was highly sensitive as participants were re-
porting on informal practices, and this will likely have affected the way that participants rep-
resented themselves in the interviews. The focus of many pharmacy workers on the public
health justification for providing safe abortion, and limited discussion of financial motiva-
tions, may reflect the sensitive nature of the topic. Despite the sensitivity of the topic, most
pharmacy workers did describe providingMAwithout a prescription, suggesting that the in-
terviewers were able to put the participants sufficiently at ease. Participants within the phar-
macy were selected on the recommendation of pharmacy owners, which may have led to
us interviewing higher level staff rather than the lower level attendants who are known to
most frequently serve clients. However, the perspectives of formal, higher level pharmacy
staff will likely influence the practices of lower level attendants and the overall practice of the
pharmacy. Pharmacy staff were selected from pharmacies that had agreed to take part in a
larger intervention study. These pharmacies may be more comfortable providing MA, less
risk averse, more conscientious about client care, or more likely to provide MA within the
legal restrictions, than pharmacies that did not wish to be included in the intervention. It is
also possible that their involvement in the intervention may have affected their perspectives
on MA, but the intervention involved only the display of promotional materials within the
pharmacies, so was not expected to alter the pharmacy workers’ knowledge or behavior. Our
sample was small, and limited to Lusaka, and further research could explore how the situa-
tion varies in other cities and towns in Zambia, and importantly in more rural pharmacies.
Finally, this paper does not include the perspectives of clients, other types of health provider,
or policy makers. Though we did aim to interview clients as well as pharmacy staff, low par-
ticipation rates led us to end recruitment early, as few clients were willing to be interviewed,
reflecting the sensitivity surrounding this practice of purchasing MA from pharmacies.
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Including the perspectives of other types of health care provider, or those involved in set-
ting health policy, could provide additional context to some of these findings.
CONCLUSION
This study highlights how limited implementation of abortion law reform and health sys-
tem failures surrounding abortion have turned pharmacy workers into reluctant gatekeepers
of safe abortion methods in Zambia. Motivated by their duty of care and desire to prevent
unsafe abortion, as well as financial gain, pharmacy workers expand access to safe abortion
methods. However, pharmacy workers’ motivation to protect themselves from legal and busi-
ness risk can perpetuate inequalities in access to safe abortion care. Laws, policies, and reg-
ulations must be adapted to ensure women can access high quality abortion care. Removing
the requirement for multiple doctors’ signatures, enabling task sharing of abortion to mi-
dlevel providers and pharmacists, increasing public awareness of abortion laws and rights,
values clarification and attitude transformation to reduce provider refusal, and increasing
the ease with which pharmacists and women can access prescriptions through telemedicine
approaches could improve legal access to safe abortion in Zambia.
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